92.38
前日終値:
$91.92
開ける:
$92.58
24時間の取引高:
1.00M
Relative Volume:
0.44
時価総額:
$18.24B
収益:
$7.68B
当期純損益:
$903.80M
株価収益率:
20.76
EPS:
4.45
ネットキャッシュフロー:
$1.14B
1週間 パフォーマンス:
+0.23%
1か月 パフォーマンス:
+0.12%
6か月 パフォーマンス:
-14.49%
1年 パフォーマンス:
-18.51%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
名前
Zimmer Biomet Holdings Inc
セクター
電話
(574) 267-6131
住所
345 EAST MAIN STREET, WARSAW, IN
ZBH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ZBH
Zimmer Biomet Holdings Inc
|
92.38 | 18.24B | 7.68B | 903.80M | 1.14B | 4.45 |
![]()
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
2024-09-10 | 開始されました | Wolfe Research | Peer Perform |
2024-07-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
2024-05-30 | 開始されました | Goldman | Neutral |
2024-05-21 | アップグレード | Argus | Hold → Buy |
2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
2023-10-20 | 開始されました | ROTH MKM | Neutral |
2023-08-28 | アップグレード | BTIG Research | Neutral → Buy |
2023-05-03 | アップグレード | BofA Securities | Underperform → Neutral |
2023-04-11 | アップグレード | Evercore ISI | In-line → Outperform |
2023-03-31 | アップグレード | Jefferies | Underperform → Hold |
2023-03-29 | 開始されました | UBS | Sell |
2023-03-10 | アップグレード | Piper Sandler | Neutral → Overweight |
2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2023-01-05 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
2022-11-23 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2022-10-18 | 開始されました | Barclays | Underweight |
2022-10-12 | 開始されました | Jefferies | Underperform |
2022-05-27 | ダウングレード | Needham | Buy → Hold |
2022-04-13 | ダウングレード | Truist | Buy → Hold |
2022-04-01 | ダウングレード | Citigroup | Buy → Neutral |
2022-03-02 | 再開されました | BofA Securities | Underperform |
2022-03-02 | ダウングレード | Loop Capital | Buy → Hold |
2022-02-08 | ダウングレード | Canaccord Genuity | Buy → Hold |
2022-02-08 | 繰り返されました | Citigroup | Buy |
2022-02-08 | 繰り返されました | Deutsche Bank | Hold |
2022-02-08 | 繰り返されました | JMP Securities | Mkt Outperform |
2022-02-08 | 繰り返されました | JP Morgan | Neutral |
2022-02-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2022-02-08 | 繰り返されました | Stifel | Buy |
2022-02-08 | 繰り返されました | Truist | Buy |
2022-02-08 | 繰り返されました | UBS | Neutral |
2022-02-08 | 繰り返されました | Wells Fargo | Underweight |
2022-02-02 | ダウングレード | UBS | Buy → Neutral |
2022-01-19 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
2022-01-10 | ダウングレード | Mizuho | Buy → Neutral |
2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
2021-12-09 | ダウングレード | Needham | Strong Buy → Buy |
2021-12-07 | 開始されました | Loop Capital | Buy |
2021-11-23 | ダウングレード | Argus | Buy → Hold |
2021-09-14 | 再開されました | Raymond James | Mkt Perform |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-09 | アップグレード | Northland Capital | Market Perform → Outperform |
2021-01-04 | アップグレード | Evercore ISI | In-line → Outperform |
2020-12-18 | 繰り返されました | Needham | Strong Buy |
2020-10-20 | 開始されました | Northland Capital | Market Perform |
2020-09-11 | 開始されました | Wolfe Research | Outperform |
2020-08-05 | 繰り返されました | Needham | Strong Buy |
2020-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
2020-04-09 | ダウングレード | Evercore ISI | Outperform → In-line |
2020-04-07 | 繰り返されました | Needham | Strong Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Buy |
2020-01-08 | 開始されました | SunTrust | Buy |
2020-01-07 | アップグレード | Piper Jaffray | Neutral → Overweight |
2020-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
2019-12-04 | アップグレード | Raymond James | Outperform → Strong Buy |
2019-10-07 | アップグレード | BTIG Research | Neutral → Buy |
2019-09-18 | アップグレード | Canaccord Genuity | Hold → Buy |
2019-08-12 | アップグレード | Argus | Hold → Buy |
2019-07-30 | アップグレード | Barclays | Underweight → Equal Weight |
2019-07-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
2019-06-11 | アップグレード | Bernstein | Underperform → Mkt Perform |
2019-04-24 | アップグレード | Needham | Buy → Strong Buy |
すべてを表示
Zimmer Biomet Holdings Inc (ZBH) 最新ニュース
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN
Highridge sells bone healing business to Avista - BioWorld MedTech
Treace Medical Concepts (TMCI) Sues Zimmer Biomet Over Patent Infringements - GuruFocus
Zimmer Biomet Facing Patent Infringement Lawsuit From Treace Medical - marketscreener.com
Treace Medical sues Zimmer Biomet over patent infringement - Investing.com Australia
Treace Medical sues Zimmer Biomet over patent infringement By Investing.com - Investing.com Nigeria
Zimmer Biomet faces patent suit from Treace Medical (TMCI) - Seeking Alpha
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology - The Manila Times
Treace Medical files patent infringement suit against Zimmer Biomet - TipRanks
Treace Medical Concepts Files Patent Infringement Suit Against Zimmer Biomet - marketscreener.com
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zimmer Biomet Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 31, 2017ZBH - ACCESS Newswire
zimmer biomet shareholders approve stock incentive plan amendments By Investing.com - Investing.com South Africa
Rep. Robert Bresnahan, Jr. Sells Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares - Defense World
zimmer biomet shareholders approve stock incentive plan amendments - Investing.com
Zimmer Biomet Approves Amendments at Annual Meeting - TipRanks
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24 - Yahoo Finance
Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24 - simplywall.st
Zimmer Biomet sets quarterly dividend at $0.24 per share By Investing.com - Investing.com South Africa
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Knee Replacement Market Detailed in New Research ReportZimmer Biomet, Stryker - openPR.com
Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable Around July 31 to Shareholders of Record on June 26 - marketscreener.com
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 - GuruFocus
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 | ZBH Stock News - GuruFocus
Zimmer Biomet sets quarterly dividend at $0.24 per share - Investing.com
Zacks Research Forecasts Weaker Earnings for Zimmer Biomet - Defense World
Zimmer Biomet Chairman, President and CEO Ivan Tornos Joins OREF Board of Trustees - Yahoo Finance
A Look Back at Surgical Equipment & ConsumablesDiversified Stocks’ Q1 Earnings: Zimmer Biomet (NYSE:ZBH) Vs The Rest Of The Pack - Yahoo Finance
Zacks Research Forecasts Reduced Earnings for Zimmer Biomet - Defense World
Zimmer Biomet names Kevin Thornal as group president, global biz - Medical Buyer
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas - The Malaysian Reserve
Zimmer Biomet Holdings (ZBH) Appoints Kevin Thornal as Group Pre - GuruFocus
Orthopedic Oncology Market is Booming WorldwideStryker, Zimmer Biomet - openPR.com
Zimmer hires former Nevro CEO Kevin Thornal - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Appoints Kevin Thornal as Group President - GuruFocus
Zimmer Biomet names new Group President for Americas By Investing.com - Investing.com South Africa
Former Nevro CEO joins Zimmer Biomet as group president - MassDevice
Hip Replacement Market is Booming WorldwideZimmer Biomet, Stryker - openPR.com
Zimmer Biomet Appoints Kevin Thornal As Group President, Global Businesses And The Americas - marketscreener.com
Zimmer Biomet Appoints Kevin Thornal as Group President - TipRanks
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas | ZBH Stock News - GuruFocus
Zimmer Biomet names new Group President for Americas - Investing.com
Saudi Arabia Dental Implants Market Trends and Forecasts 2020-2024 & 2025-2030, Competitive Analysis of Masar Medical, Keydent, Zimmer Biomet, Dentsply Sirona, and Henry Schein - Yahoo
Zimmer Biomet Holdings (ZBH) Stock Analysis: Navigating a Potential 17.25% Upside in the Healthcare Sector - DirectorsTalk Interviews
Zimmer Biomet’s SWOT analysis: orthopedic giant’s stock navigates challenges By Investing.com - Investing.com Nigeria
Zimmer Biomet’s SWOT analysis: orthopedic giant’s stock navigates challenges - Investing.com
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Malaysian Reserve
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | ZBH Stock News - GuruFocus
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues - TradingView
Zimmer Biomet Holdings, Inc. (ZBH): Among the Most Oversold Stocks to Buy According to Billionaires - Insider Monkey
Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
Zimmer Biomet Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Zimmer Biomet Holdings Inc (ZBH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):